Quercetin inhibiting the PD-1/PD-L1 interaction for immune-enhancing cancer chemopreventive agent

Phytother Res. 2021 Nov;35(11):6441-6451. doi: 10.1002/ptr.7297. Epub 2021 Sep 24.

Abstract

Targeting the PD-1/PD-L1 immune checkpoints has achieved significant positive results in the treatment of multiple cancers. Quercetin is one of the most abundant dietary flavonoids found in various vegetables and fruits, and has a wide range of biological activities including immunomodulation. Here we report that quercetin dihydrate was screened and shown to inhibit the PD-1/PD-L1 interaction. Treatment with quercetin dihydrate promoted the killing activity of T cells on MDA-MB-231 and NCI-H460 cancer cells. Experiments using the xenograft mouse model showed that the growth rate of tumor volumes and masses in the quercetin dihydrate-treated mice were decreased. Immunohistochemistry of the tumors showed that CD8, GZMB, and IFN-γ were increased in the quercetin dihydrate-treated mice. These results suggest that quercetin dihydrate attenuates the inhibitory effect of PD-L1 on T cells by inhibiting the PD-1/PD-L1 interaction, which has an exciting potential to be used as a cancer chemopreventive agent.

Keywords: PD-1/PD-L1; cancer preventive agent; immunomodulation; quercetin.

MeSH terms

  • Animals
  • B7-H1 Antigen*
  • CD8-Positive T-Lymphocytes
  • Mice
  • Neoplasms*
  • Programmed Cell Death 1 Receptor
  • Quercetin / pharmacology
  • T-Lymphocytes

Substances

  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor
  • Quercetin